Furthermore, we showed that SBFI-1143 inhibits levels of genes that are identified in the lineage of plasticity-related prostate cancer cells and characterized by low AR expression, stemness characteristics, high levels of Hyaluronan Mediated Motility Receptor (HMMR), and are associated with a poor prognosis. The gene discussed is AR; the disease is prostate cancer.